Adial Pharmaceuticals, Inc.
ADIL
$0.685
-$0.03-4.20%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -13.20M | -13.05M | -12.24M | -8.69M | -5.12M |
| Total Depreciation and Amortization | 400.00 | 400.00 | 400.00 | 400.00 | 400.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.89M | 6.00M | 6.09M | 3.63M | -889.80K |
| Change in Net Operating Assets | 386.20K | 356.30K | -233.80K | -1.07M | -794.20K |
| Cash from Operations | -6.92M | -6.69M | -6.39M | -6.13M | -6.81M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | 350.00K | 700.00K | 1.50M | 1.50M |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 350.00K | 700.00K | 1.50M | 1.50M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 7.85M | 7.85M | 4.38M | 3.97M | 750.40K |
| Repurchase of Common Stock | -- | 0.00 | -1.70K | -1.70K | -1.70K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 3.38M | 3.38M | 3.38M | 3.38M |
| Cash from Financing | 7.85M | 11.23M | 7.76M | 7.35M | 4.13M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 923.40K | 4.89M | 2.07M | 2.71M | -1.17M |